Disease |
|
|
|
|
|
|
Five Yr: 2017-2021 |
Ten Yr: 2012-2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022* |
Mean |
Median |
Mean |
Median |
Babesiosis |
161 |
165 |
158 |
193 |
195 |
51 |
174 |
165 |
159 |
163 |
Campylobacteriosis |
278 |
326 |
355 |
206 |
278 |
220 |
289 |
278 |
236 |
224 |
Chikungunya |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
8 |
0.5 |
Chlamydia |
5,282 |
5,487 |
5,717 |
4,714 |
5,199 |
4,263 |
5,280 |
5,282 |
4,892 |
4,844 |
Coccidioidomycosis |
3 |
4 |
1 |
0 |
1 |
1 |
2 |
1 |
1 |
1 |
COVID-19 (SARS-CoV-2) |
|
|
|
86,882 |
140,322 |
199,714 |
N/A |
N/A |
N/A |
N/A |
CJD (non-variant) |
3 |
4 |
3 |
0 |
0 |
0 |
2 |
3 |
2 |
1 |
Cryptosporidosis |
33 |
90 |
63 |
23 |
34 |
60 |
49 |
34 |
33 |
24 |
Cyclosporiasis |
5 |
3 |
31 |
4 |
4 |
2 |
9 |
4 |
8 |
4 |
EEE Virus |
0 |
0 |
3 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Ehrlichiosis / Anaplasmosis |
225 |
228 |
196 |
110 |
155 |
56 |
183 |
196 |
161 |
155.5 |
Giardiasis |
45 |
56 |
79 |
31 |
55 |
51 |
53 |
55 |
54 |
50 |
Gonorrhea |
1,087 |
1,336 |
1,516 |
1,399 |
1,681 |
1,145 |
1,404 |
1,399 |
986 |
898 |
Haemophilus Influenzae, invasive |
18 |
25 |
24 |
12 |
15 |
6 |
19 |
18 |
19 |
18.5 |
Hepatitis A |
6 |
7 |
6 |
4 |
1 |
1 |
5 |
6 |
5 |
4 |
HIV (Human Immunodeficiency Virus) |
81 |
72 |
73 |
54 |
67 |
59 |
74 |
74 |
76 |
79 |
Legionellosis |
50 |
73 |
48 |
36 |
87 |
43 |
59 |
50 |
46 |
41.5 |
Listeriosis |
7 |
7 |
2 |
5 |
6 |
4 |
5 |
6 |
5 |
5 |
Lyme Disease |
1,132 |
1,111 |
971 |
839 |
980 |
2,222 |
1,007 |
980 |
871 |
916 |
Malaria |
13 |
12 |
13 |
2 |
7 |
9 |
9 |
12 |
13 |
13 |
Measles |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Meningococcal Disease |
2 |
1 |
3 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
Multisystem Inflammatory Syndrome Associated with COVID-19 (MIS-C) |
|
|
|
12 |
18 |
6 |
N/A |
N/A |
N/A |
N/A |
Mumps |
29 |
5 |
9 |
0 |
2 |
0 |
9 |
5 |
5 |
2.5 |
Pertussis |
84 |
34 |
44 |
4 |
0 |
0 |
33 |
34 |
67 |
64 |
Invasive Pneumococcal Disease |
64 |
59 |
85 |
51 |
32 |
53 |
58 |
59 |
64 |
64.5 |
Rocky Mountain Spotted Fever |
15 |
9 |
0 |
0 |
1 |
0 |
5 |
1 |
5 |
2 |
Rubella (including congenital) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Salmonellosis |
148 |
175 |
152 |
115 |
137 |
141 |
145 |
148 |
138 |
138.5 |
Shiga-toxin positive E. coli |
14 |
45 |
48 |
28 |
45 |
39 |
36 |
45 |
21 |
12.5 |
Shigellosis |
44 |
59 |
85 |
32 |
49 |
56 |
54 |
49 |
65 |
39 |
Streptococcus, Group A |
39 |
43 |
53 |
34 |
30 |
32 |
40 |
39 |
37 |
37 |
Streptococcus, Group B |
84 |
114 |
90 |
101 |
135 |
101 |
105 |
101 |
85 |
81 |
Syphilis (congenital) |
0 |
0 |
0 |
1 |
2 |
4 |
1 |
0 |
0 |
0 |
Syphilis (late) |
79 |
118 |
213 |
128 |
237 |
186 |
155 |
128 |
100 |
83 |
Syphilis (primary, secondary, and early latent) |
142 |
167 |
210 |
186 |
328 |
162 |
207 |
186 |
155 |
144.5 |
Tuberculosis |
13 |
19 |
14 |
7 |
17 |
15 |
14 |
14 |
18 |
18 |
Varicella |
74 |
67 |
64 |
32 |
32 |
39 |
54 |
64 |
55 |
53.5 |
Vibriosis |
15 |
13 |
12 |
10 |
13 |
12 |
13 |
13 |
11 |
11.5 |
West Nile Virus |
2 |
1 |
0 |
0 |
2 |
1 |
1 |
1 |
1 |
1 |
Footnotes:
* 2022 preliminary data was extracted from the RI National Electronic Disease Surveillance System (NEDSS) on December 14, 2022, and is subject to change. |